These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 34422405)

  • 1. Efficacy and Safety of 0.03% Atropine Eye Drops in Controlling Myopia Progression: A One-Year Prospective Clinical Study.
    Simonaviciute D; Grzybowski A; Gelzinis A; Zemaitiene R
    J Clin Med; 2024 May; 13(11):. PubMed ID: 38892929
    [No Abstract]   [Full Text] [Related]  

  • 2. Five-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study: Phase 4 Report.
    Zhang XJ; Zhang Y; Yip BHK; Kam KW; Tang F; Ling X; Ng MPH; Young AL; Wu PC; Tham CC; Chen LJ; Pang CP; Yam JC
    Ophthalmology; 2024 Sep; 131(9):1011-1020. PubMed ID: 38494130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Meta-Analysis Assessing Change in Pupillary Diameter, Accommodative Amplitude, and Efficacy of Atropine for Myopia Control.
    Tran HDM; Sankaridurg P; Naduvilath T; Ha TTX; Tran TD; Jong M; Coroneo M; Tran YH
    Asia Pac J Ophthalmol (Phila); 2021 Aug; 10(5):450-460. PubMed ID: 34456234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is 0.01% Atropine an Effective and Safe Treatment for Myopic Children? A Systemic Review and Meta-Analysis.
    Tsai HR; Chen TL; Wang JH; Huang HK; Chiu CJ
    J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: Saxena et al.: Atropine for treatment of childhood myopia in India: multicentric randomized trial (Ophthalmology. 2021;128:1367-1369).
    Zhang XJ; Wang YM; Pang CP; Yam JC
    Ophthalmology; 2021 Dec; 128(12):e214-e215. PubMed ID: 34452762
    [No Abstract]   [Full Text] [Related]  

  • 6. Continued Increase of Axial Length and Its Risk Factors in Adults With High Myopia.
    Du R; Xie S; Igarashi-Yokoi T; Watanabe T; Uramoto K; Takahashi H; Nakao N; Yoshida T; Fang Y; Ohno-Matsui K
    JAMA Ophthalmol; 2021 Oct; 139(10):1096-1103. PubMed ID: 34436537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence Trend of Myopia after Promoting Eye Care in Preschoolers: A Serial Survey in Taiwan before and during the Coronavirus Disease 2019 Pandemic.
    Yang YC; Hsu NW; Wang CY; Shyong MP; Tsai DC
    Ophthalmology; 2022 Feb; 129(2):181-190. PubMed ID: 34425129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of coronavirus disease 2019 on myopic progression in children treated with low-concentration atropine.
    Yum HR; Park SH; Shin SY
    PLoS One; 2021; 16(9):e0257480. PubMed ID: 34520481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myopia Progression as a Function of Sex, Age, and Ethnicity.
    Jones-Jordan LA; Sinnott LT; Chu RH; Cotter SA; Kleinstein RN; Manny RE; Mutti DO; Twelker JD; Zadnik K;
    Invest Ophthalmol Vis Sci; 2021 Aug; 62(10):36. PubMed ID: 34463720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of auricular acupressure combined with acupuncture for juvenile pseudomyopia.
    Zhu YN; Chen YY; Zou T; Cao P
    Medicine (Baltimore); 2023 Sep; 102(37):e35018. PubMed ID: 37713874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IMI 2023 Digest.
    Sankaridurg P; Berntsen DA; Bullimore MA; Cho P; Flitcroft I; Gawne TJ; Gifford KL; Jong M; Kang P; Ostrin LA; Santodomingo-Rubido J; Wildsoet C; Wolffsohn JS
    Invest Ophthalmol Vis Sci; 2023 May; 64(6):7. PubMed ID: 37126356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choroidal thickness, myopia, and myopia control interventions in children: a Meta-analysis and systemic review.
    Meng QY; Miao ZQ; Liang ST; Wu X; Wang LJ; Zhao MW; Guo LL
    Int J Ophthalmol; 2023; 16(3):453-464. PubMed ID: 36935799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Non-Infectious Corneal Injury: Review of Diagnostic Agents, Therapeutic Medications, and Future Targets.
    Dang DH; Riaz KM; Karamichos D
    Drugs; 2022 Feb; 82(2):145-167. PubMed ID: 35025078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Randomized Controlled Trial of the Effect of 0.01% Atropine Eye Drops Combined with Auricular Acupoint Stimulation on Myopia Progression.
    Kong XH; Zhao Y; Chen Z; Zeng L; Han R; Dong XQ; Guo XC; Shi Z; Yang G; Yang YT; Zhang D; Zhou XT; Ma XP
    J Ophthalmol; 2021; 2021():5585441. PubMed ID: 34422405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of Auricular Acupoint Stimulation to 0.01% Atropine for Myopia: 12-Month Results from a Randomized Trial.
    Kong X; Yang G; Chen Z; Han R; Zhao Y; Zeng L; Guo X; Shi Z; Zhang D; Yang Y; Liu J; Zhou X; Ma X
    J Integr Complement Med; 2023 Sep; 29(9):574-583. PubMed ID: 36971804
    [No Abstract]   [Full Text] [Related]  

  • 16. Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control: A Randomized Clinical Trial.
    Repka MX; Weise KK; Chandler DL; Wu R; Melia BM; Manny RE; Kehler LAF; Jordan CO; Raghuram A; Summers AI; Lee KA; Petersen DB; Erzurum SA; Pang Y; Lenhart PD; Ticho BH; Beck RW; Kraker RT; Holmes JM; Cotter SA;
    JAMA Ophthalmol; 2023 Aug; 141(8):756-765. PubMed ID: 37440213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of low-concentration atropine combined with auricular acupoint stimulation in myopia control.
    Cheng HC; Hsieh YT
    Complement Ther Med; 2014 Jun; 22(3):449-55. PubMed ID: 24906584
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.